פרופ' עינת רע ויזר (אבן-ספיר)

• Education: Tel-Aviv University, Sackler School of Medicine, MD, graduated in 1982.

           Technion, Haifa, PhD, graduated in 1991.

           Dalhaousie University, Halifax Canada- Fellowship 1991-1993.

• Position: Head. Dept of Nuclear medicine and PET-CT, Tel Aviv Sourasky Medical Center, since 1996.

• Academic Degree: Full professor of imaging.  Tel-Aviv University, Sackler School of Medicine.

Member of the North-American Society of Nuclear Medicine, European Society of Nuclear Medicine, Israeli Society of Nuclear Medicine and Academy of Molecular Imaging.

Member of the editorial board of the Journal of Nuclear Medicine Reviewer of the Journal of Nuclear Medicine, European Journal of Nuclear Medicine and Molecular Imaging, Investigative Radiology and Surgical Oncology.

Research interests

1. Hybrid imaging techniques, SPECT/CT and PET/CT

2. molecular breast imaging – MBI

3. Novel tumor-specific radiotracers

4. In vivo characterization of tumor aggressiveness and proliferation

5. Functional brain imaging of craving (Ecstasy, Marihuana and Nicotine).

6. In vivo assessment of Dopamine- receptors in family members of patients with Parkinson disease.

• Publications: over 120 peer-reviewed articles, 9 book chapters

Selected publications:

1. O. Jacobson, Y. Bechor, A. Icar, N. Novak, A. Birman, H. Marom, L. Fadeeva, E. Golan, I. Leibovitz, M. Gutman, E. Even-Sapir, M. Gozin and E. Mishani. Prostate Cancer PET Bioprobes: Synthesis of [¹⁸F]-Radiolabeled Hydroxyflutamide Derivatives. Bioorg Med Chem. 2005 Nov 15;13(22):6195-205.

2. H. Lerman U. Metser , G. Lievshitz , F. Sperber S. Schneebaum , E. Even-Sapir Lymphoscintigraphic sentinel node identification in patients with breast cancer: The  role of SPECT-CT. European Journal of Nuclear Medicine and Molecular Imaging 2006 33:329-337. 

3. R. Essner, T Belhocine,T, AM Scott, E. Even-Sapir. Novel imaging techniques in melanoma. Surg Oncol Clin N Am. 2006 Apr;15(2):253-83

4. E. Even-Sapir, U. Metser,  E. Mishani,  G. Lievshitz, H. Lerman, and I. Leibovitch. The detection of bone metastases in patients with high-risk prostate cancer. ^99mTc-MDP planar bone scintigraphy, single and multi-field-of view SPECT, ¹⁸F-Fluoride PET and ¹⁸F-Fluoride PET-CT. J Nucl Med.  2006; 47:287-297.

5. E. Even-Sapir, H. Lerman,  M. Gutman, G. Lievshitz,  L. Zuriel, A. Polliack,  M. Inbar, and U. Metser.  The presentation of malignant tumors and pre-malignant lesions incidentally found on PET-CT. European Journal of Nuclear Medicine and Molecular Imaging 2006 May;33(5):541-52.

6. E. Even-Sapir, E. Mishani, G. Flusser and U. Metser ¹⁸F-FLUORIDE PET and PET/CT. Seminars in Nucl Med 2007;37:462-469.

7. E. Even-Sapir .  PET-CT in Malignant Bone Disease. Seminars in Musculoskeletal Radiology 2007 Dec;11(4):312-21.

8. Even-Sapir E, Keidar Z, Bar-Shalom R. Hybrid imaging (SPECT/CT and PET/CT)--improving the diagnostic accuracy of functional/metabolic and anatomic imaging. Semin Nucl Med. 2009 Jul;39(4):264-75.

9. E. Even-Sapir, M. Inbar. The role of PET in women with genetic/ familial high- risk for breast and/or ovarian cancer. Lancet Oncol. 2010 Sep;11(9):899-905

10. Weinstein A, Greif J, Yemini Z, Lerman H, Weizman A, Even-Sapir E. Attenuation of cue-induced smoking urges and brain reward activity in smokers treated successfully with bupropion. J. Psychopharmacol. 2010 Jun;24(6):829-38.